Kim Sablich - Net Worth and Insider Trading
Kim Sablich Net Worth
The estimated net worth of Kim Sablich is at least $5 Million dollars as of 2024-11-13. Kim Sablich is the EVP, GM of U.S., Commercial Ma of Jazz Pharmaceuticals PLC and owns about 30,560 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Kim Sablich is also the Chief Commercial Officer of Myovant Sciences Ltd and owns about 58,905 shares of Myovant Sciences Ltd (MYOV) stock worth over $2 Million. Details can be seen in Kim Sablich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kim Sablich has not made any transactions after 2023-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kim Sablich
Kim Sablich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kim Sablich owns 3 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , Myovant Sciences Ltd (MYOV) , and Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of Kim Sablich’s form 4 insider trades.
Insider Ownership Summary of Kim Sablich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2023-03-08 | EVP & GM & North America |
| MYOV | Myovant Sciences Ltd | 2020-03-18 | Chief Commercial Officer |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-11 | director |
Kim Sablich Latest Holdings Summary
Kim Sablich currently owns a total of 2 stocks. Among these stocks, Kim Sablich owns 30,560 shares of Jazz Pharmaceuticals PLC (JAZZ) as of March 8, 2023, with a value of $4 Million and a weighting of 71.06%. Kim Sablich also owns 58,905 shares of Myovant Sciences Ltd (MYOV) as of March 18, 2020, with a value of $2 Million and a weighting of 28.94%.
Latest Holdings of Kim Sablich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2023-03-08 | 30,560 | 127.70 | 3,902,512 |
| MYOV | Myovant Sciences Ltd | 2020-03-18 | 58,905 | 26.98 | 1,589,257 |
Holding Weightings of Kim Sablich
Kim Sablich Form 4 Trading Tracker
According to the SEC Form 4 filings, Kim Sablich has made a total of 3 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 3,013 shares on March 8, 2023, which brought Kim Sablich around $421,037.
According to the SEC Form 4 filings, Kim Sablich has made a total of 3 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Myovant Sciences Ltd is the sale of 785 shares on March 18, 2020, which brought Kim Sablich around $5,785.
Insider Trading History of Kim Sablich
- 1
Kim Sablich Trading Performance
Kim Sablich Ownership Network
Ownership Network List of Kim Sablich
Ownership Network Relation of Kim Sablich
Kim Sablich Owned Company Details
What does Jazz Pharmaceuticals PLC do?
Who are the key executives at Jazz Pharmaceuticals PLC?
Kim Sablich is the EVP & GM & North America of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include director & Executive Chairman Bruce C Cozadd , SVP & Technical Operations Mary Elizabeth Henderson , and VP & Finance& PAO Patricia Carr .
Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary
Over the past 18 months, Kim Sablich made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Jennifer E. Cook .
In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.
Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jazz Pharmaceuticals PLC Insider Transactions
Kim Sablich Mailing Address
Above is the net worth, insider trading, and ownership report for Kim Sablich. You might contact Kim Sablich via mailing address: C/o Myovant Sciences Inc., 2000 Sierra Point Parkway, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
